All Pharma News
Karuna`s captains set sail in new neuropsychiatric biotech

Karuna`s captains set sail in new neuropsychiatric biotech
James Waldron FIERCE BIOTECH
09 Apr 2024
Share Share
BMS Completes Acquisition of PureTech`s Founded Entity Karuna for $14 Billion

BMS Completes Acquisition of PureTech`s Founded Entity Karuna for $14 Billion
BUSINESSWIRE
18 Mar 2024
Share Share
Karuna Therapeutics set to merge with Bristol-Myers Squibb

Karuna Therapeutics set to merge with Bristol-Myers Squibb
PRESS RELEASE
13 Mar 2024
Share Share
Karuna ‘vigorously’ denies wrongdoing in shareholder lawsuit

Karuna ‘vigorously’ denies wrongdoing in shareholder lawsuit
Gabrielle Masson FIERCE BIOTECH
01 Mar 2024
Share Share
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
22 Feb 2024
Share Share
Karuna shareholder sues biotech over BMS merger

Karuna shareholder sues biotech over BMS merger
FIERCE BIOTECH
15 Feb 2024
Share Share
Third Rock adds 3 new venture partners, including Karuna’s Paul

Third Rock adds 3 new venture partners, including Karuna’s Paul
FIERCE BIOTECH
25 Jan 2024
Share Share
Another company bid against BMS` $14B offer for Karuna

Another company bid against BMS` $14B offer for Karuna
FIERCE BIOTECH
22 Jan 2024
Share Share
Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion

Bristol Myers Squibb to buy Karuna Therapeutics for US$ 14 billion
INDIAN PHARMA POST
24 Dec 2023
Share Share
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bln
REUTERS
23 Dec 2023
Share Share